Company Active LTD

Company profile

Innova Biosciences Ltd

UK company 04415674, incorporated on 12 April 2002.

Innova Biosciences Ltd is a UK company with status Active founded in 2002 based in East of England.

Company number

04415674

Incorporated

12 Apr 2002

Companies House status

Active

Company identity

Founded / incorporated

12 April 2002

Company number 04415674

Verify at Companies House

Legal name

INNOVA BIOSCIENCES LTD

Company type

Private Limited Company

Region

East of England

Registered address

DISCOVERY DRIVE

CAMBRIDGE BIOMEDICAL CAMPUS

CAMBRIDGE

ENGLAND

CB2 0AX

Insolvency history

Corporate ownership

Updated 07 Jul 2026 09:49

5 levels 1 ultimate controller

Company Active LTD

Innova Biosciences Ltd

CRN 04415674

Direct controller Active LTD

Expedeon Holdings Limited

CRN 06785444

Intermediate controller Active PLC

Abcam PLC

CRN 03509322

Intermediate controller Active LTD

Diadem Holdco Limited

CRN 15096793

Intermediate controller Active PRIVATE-UNLIMITED

Launchchange Holding Company

CRN 03259276

Intermediate controller Active LTD

Pall European Holdings Limited

CRN 08818341

Ultimate controller

02103594

CRN 02103594

Company events

Reference milestones and recent Companies House filing stream events.

6 events

14 Apr

2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep

2026

Accounts due

Accounts Due

Next accounts due date

19 Aug

2026

Accounts With Accounts Type Full

Accounts PDF pending

AA | Transaction MzUzOTMwMzU1NWFkaXF6a2N4 | Paper/PDF filed

Published 19 Aug 2026 23:05

31 Mar

2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec

2024

Accounts filed

Accounts

Last accounts made up date

12 Apr

2002

Incorporated

Inception

Company registered at Companies House

Public funding

1 award

First funded

2012

Funded years

2012

Age at first award

9 years

Projects

2012 GRD Development of Prototype Lead participant

Easy-to-Use Nanoparticle Conjugation Kits

1 Mar 2012 to 28 Feb 2014

Awarded

£206,949

Total cost £459,887

Innova Biosciences develops technologies that allow coloured or other detectable substances (‘labels’) to be attached irreversibly to an antibody to form a hybrid molecule called either an ‘antibody conjugate’ or a ‘labelled antibody’. Innova uses uniquely simple processes that save operator time, improve yield of antibody conjugates and minimise batch-to...

Product types

GRD Development of Prototype